This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Blood Cancer (leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma) Treatment Market

North America holds the largest market share in blood cancer treatment, accumulating 38.2% share during the forecast period.

Blood Cancer (leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma) Treatment Market by Application, End User & Region - Forecast 2022 - 2032

Blood Cancer (leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma) Treatment Market Snapshot (2022-2032)

[309 Pages Report] Global blood cancer (leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma) treatment demand is anticipated to be valued at US$ 5,489.3 Million in 2022, forecast to grow at a CAGR of 10.2% to be valued at US$ 12,943.6 Million from 2022 to 2032.

Growth is attributed to increasing involvement of key and prominent companies in the R&D for Blood cancer (leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma) Treatment across the globe.

Data Points

Key Statistics

Growth Rate (2016-2021)

10.8% CAGR

Expected Market Value (2022)

US$ 5,489.3 Million

Anticipated Forecast Value (2032)

US$ 12,943.6 Million

Projected Growth Rate (2022-2032)

10.2% CAGR

Blood cancer (leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma) is a general term used for the cancers that affect blood, bone marrow or lymphatic system. Most of these cancers start in bone marrow where blood cells (RBC, WBC and platelets) are produced from bone marrow stem cells.

In cancerous condition, differentiation of bone marrow stem cells is interrupted to produce abnormal blood cells which hamper the normal functioning of the blood. There are 4 types of blood cancer (leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma)s such as leukemia, Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL) and multiple myeloma.

Factors such as increasing government initiatives for cancer awareness, rising prevalence of cancer worldwide, and strong R&D initiatives from key players, along with the increasing demand for personalized medicine are expected to augment the growth of the Blood cancer (leukemia, non-hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma) Treatment Market during the forecast period.

Strong costs attributed to certain therapeutics in the Blood cancer (leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma) Treatment Market is one of the major factors that is expected to hamper the market growth in the certain emerging regions over the analysis period.

Customize this Report

Let us know your requirement to get
100% FREE customization

Which Are Some Prominent Drivers Spearheading Blood Cancer (Leukemia, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Multiple Myeloma) Treatment Market Growth?

High incidence rate of blood cancers in US (leukemia-13.0, NHL-19.8, HL-2.7, myeloma-6.7 cases per 100,000 population in 2014) is one of the major factors for the growth of blood cancer treatment market in the US. In addition, advancement in technology, personalized medicine, cost effective treatment procedures are few other factors that are expected to fuel the growth of global blood cancer treatment market during the forecast period.

Moreover, increasing involvement of key and prominent companies in the R&D is leading to strong pipeline candidates, which is another factor that is anticipated to boost the growth of the blood cancer treatment market over the analysis period.

Many biopharmaceutical market players like Spectrum Pharmaceuticals and Amgen, are showing increasing interest for the development of new products. This increasing interest into treatment products is due to increasing number of individuals are suffering from blood cancer.

For instance, Kura Oncology is conducting a clinical trial for a pipeline candidate called tipifarnib for the disease indication of peripheral T-cell lymphoma and currently, the clinical trial is in Phase II, and received the fast-track designation from the FDA in March 2020. This factor is anticipated to further drive the growth of the blood cancer treatment market during forecast period.

What Are The Challenges Faced By The Blood Cancer Treatment Industry?

The divergent nature of blood cancers and increasing stringency in the regulatory requirements are some of the major factors that are expected to impede the growth of the blood cancer treatment market over the analysis period.

Though the prevalence of blood cancer, there are firm factors that are restraining the adoption of these therapeutics used in treatment. The significant limiting factors restraining the growth include the lower lymphoma treatment rates in emerging countries.

This is attributed to high costs of therapies. This results in a limited number of individuals undergoing this treatment, and a large number of these patients are not able to afford treatments such as immunotherapies.

Most of the times, the cost of such products is not accessible and affordable to the poor patients. In addition, the unavailability of suitable payment plans for treatment of these diseases is another major factor that is anticipated to hinder the market growth in the forthcoming years.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Why Is North America Emerging As An Opportunistic Blood Cancer Treatment Market?

In terms of regional platform, North America holds the largest market share in Blood cancer treatment market. The region is expected to accumulate a 38.2% market share in 2022. There has been a tremendous increase in cell-based research activities over the past decade.

Increasing research in the field of regenerative medicine for the treatment of leukemia and growing awareness on personalized medicine have also resulted in the growth of this market. In addition to it, the growth in this market is driven by the high prevalence and incidence of leukemia and the rising geriatric population. According to the Leukemia & Lymphoma Society, an estimated 381,774 people are living with or in remission from leukemia in the US.

The Canadian government is taking various initiatives to support leukemia research and develop novel immunotherapies. For instance, in January 2016, the Canadian government announced the provision of USD 20 million to the Centre for Commercialization of Regenerative Medicine (CCRM) to help establish a stem cell therapy development facility in Toronto (Canada).

How Is Europe Contributing To Growth Of The Blood Cancer Treatment Market?

According to Future Market Insights, Europe is expected to hold significant growth opportunities for blood cancer treatment, and is expected to reach at a share of 28.7% in 2022. The second most dominant market is expected to be Europe in the forecast period, and the reasons for the region’s high share includes the high number of individuals requiring treatment arising from the region and also the high usage of advanced therapeutics.

Moreover, factors such as the higher prevalence of lymphoma, the greater awareness amongst the patient population for lymphoma treatment, higher rate of adoption of advanced lymphoma therapeutic drugs, and the greater healthcare expenditure of the region are also expected to escalate the growth of the blood cancer treatment market during the forecast period.

In addition, constant R&D by key market players in the form of clinical trials for new drug candidate for lymphoma treatment have also boosted the market in the region.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Where Does Asia-Pacific Region Stand In The Blood Cancer Treatment Market?

According to Future Market Insights, Asia-Pacific is expected to grow with lucrative growth opportunities for blood cancer treatment market, and is expected to reach at a significant share of 24.2% in 2022.

The key reasons for the region’s growth rate include the approvals of key drugs such as Kymriah (tisagenlecleucel) in Japan for lymphoma treatment, the under tapped market potential of the region and also the existence of a large potential patient population needing treatment, which together are estimated to drive the market growth during forecast period.

Moreover, with the increasing burden of various forms of lymphoma during forecast period, the blood cancer (leukemia, non-hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma) treatment market in the region is expected to experience growth in the future due to increasing demand for lymphoma therapeutic products.

How Is Middle East & Africa Contributing To Growth Of The Blood Cancer Treatment Market?

According to Future Market Insights, Middle East & Africa is expected to provide significant growth opportunities for blood cancer treatment market, and is expected to reach at a share of 12.8% in 2022.

The strong economic growth prospects in the region is one of the major factors that is expected to propel the growth of the blood cancer (leukemia, non-hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma) treatment market over the analysis period.

Furthermore, the market is expected to develop in the future due to increasing healthcare expenditure and rising demand for advanced therapeutics by the patient population for this treatment in the region.

Role Of Start-Ups In Blood Cancer Treatment Market

There are many prominent market players in the Blood cancer (leukemia, non-hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma) treatment market such as:

  • Carer
  • 4baseCare
  • Dignite
  • Hospido
  • Onward Assist
  • Mammomobile
  • Oncophenomics
  • Tzar Labs
  • NIRAMAI
  • ONCO
  • OncoStem Diagnostics
  • Sascan
  • Adaptive Biotechnologies
  • Genoptix
  • CureMetrix
  • Enlitic
  • Entopsis
  • Freenome
  • Globavir Biosciences
  • Notable Labs
  • Oncora Medical
  • Proscia
  • SkinVision
  • Zumutor
  • Epigeneres

Players are working hand-in-hand to provide the best-in-class blood cancer treatment for enhancing the global arena. However, there are many global start-ups in the Blood cancer (leukemia, non-hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma) Treatment Market, that are stepping forward in matching the requirements of the Blood cancer (leukemia, non-hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma) Treatment domain.

  • In May 2021, Epigeneres Biotech announced its early detection cancer test (co-developed with Tzar Labs, Singapore-a specialised molecular diagnostic company), with a pioneering breakthrough in RNA bio-markers technology– a technology that can even detect cancer in stage zero (i.e., before tumour formation).
  • Founded in 2013, Zumutor Biologics ? is among a new breed of biotech startups from India focused on immuno-oncology treatment that boosts the immune system to fight cancer. What stands out about the company is its therapeutic focus on activating natural-killer cells, as opposed to the relatively more common approach of T-cell therapy.

Market Competition

Some of the key participants present in the global blood cancer (leukemia, non-hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma) treatment market include:

  • Novartis Pharmaceuticals
  • Merck & Co. Inc.
  • Bristol-Myers Squibb Company
  • AbbVie Inc.
  • Johnson & Johnson Pvt. Ltd.
  • Celgen Corporation
  • Amgen Inc.
  • Teva pharmaceutical Industries Ltd.
  • Bayer AG
  • Pfizer Inc.
  • Takeda Pharmaceutical Co. Ltd.

Attributed to the presence of such high number of participants, the market is highly competitive. While global players such as Takeda Pharmaceutical Company Limited, AstraZeneca, Bayer AG, and Novartis AG, account for a considerable market size, several regional level players are also operating across key growth regions, particularly in North America.

Recent Development

  • In June 2021, Bayer announced that the company had submitted the supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA). The company had also submitted the application for marketing authorization application (MAA) to the European Medicines Agency (EMA) for oncology treatment combination of copanlisib and rituximab in the U.S.
  • In 2021, Novartis announced strong data from the analysis of the pivotal Phase II ELARA trial of Kymriah in patients with relapsed or refractory follicular lymphoma, with one-time Kymriah infusion, which showed analysis of ELARA trial demonstrated a 66% complete response rate and 86% overall response rate.
  • In February 2021, Bristol Myers Squibb announced that the company received an approval for cancer immunotherapy from the U.S Food and Drug Administration (FDA) for certain lymphomas. The FDA approved the therapy as a treatment for adults who have certain types of non-Hodgkin lymphoma.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 10.2% from 2022 to 2032

Base Year for Estimation

2021

Market Value in 2022

US$ 5,489.3 Million

Market Value in 2032

US$ 12,943.6 Million

Historical Data

2016-2021

Forecast Period

2022-2032

Quantitative Units

Revenue in US$ Million, and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Application
  • End User
  • Region

Regions Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Middle East & Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Mexico
  • Germany
  • France
  • Italy
  • Spain
  • U.K
  • BENELUX
  • Russia
  • China
  • Japan
  • South Korea
  • India
  • Thailand
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • GCC
  • South Africa
  • Israel

Key Companies Profiled

  • Novartis Pharmaceuticals
  • Merck & Co. Inc.
  • Bristol-Myers Squibb Company
  • AbbVie Inc.
  • Johnson & Johnson Pvt. Ltd.
  • Celgen Corporation
  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Bayer AG
  • Pfizer Inc.
  • Takeda Pharmaceutical Co. Ltd.

Customization

Available Upon Request

Key Segments Profiled In The Blood Cancer (Leukemia, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Multiple Myeloma) Treatment Industry Survey

Blood Cancer Treatment Market by Application:

  • Blood Cancer Treatment for Biological/Immunotherapy Applications
  • Blood Cancer Treatment for Chemotherapy
  • Blood Cancer Treatment for Radiation Therapy
  • Blood Cancer Treatment for Targeted Therapy
  • Blood Cancer Treatment for Stem Cell Transplantation

Blood Cancer Treatment Market by End User:

  • Blood Cancer Treatment in Hospitals
  • Blood Cancer Treatment in Clinics
  • Blood Cancer Treatment in Cancer Rehabilitation Centers

Blood Cancer Treatment Market by Region:

  • North America Blood Cancer Treatment Market
  • Latin America Blood Cancer Treatment Market
  • Europe Blood Cancer Treatment Market
  • East Asia Blood Cancer Treatment Market
  • South Asia & Oceania Blood Cancer Treatment Market
  • Middle East & Africa Blood Cancer Treatment Market

Frequently Asked Questions

FMI projects the global Blood cancer (leukemia, non-hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma) Treatment market to expand at a 10.2% value CAGR by 2032

North America is expected to be the most opportunistic Blood cancer (leukemia, non-hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma) Treatment market, expanding at a 38.2% market share

Takeda Pharmaceutical Company Limited, AstraZeneca, Bayer AG, and Novartis AG are some prominent blood cancer treatment providers

Table of Content

1. Global Market - Executive Summary

    1.1. Global Market Overview

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Fact.MR Analysis and Recommendations

2. Global Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Introduction and Definition

3. Market Background and foundation Data Points

    3.1. Need of the Hour for Industries

    3.2. – Strategic Priorities

    3.3. Life Cycle Stage

    3.4. Forecast Factors: Relevance and Impact

    3.5. Investment Feasibility Matrix

    3.6. PESTLE Analysis

    3.7. Porter’s Five Forces Analysis

    3.8. Market Dynamics

        3.8.1. Drivers

        3.8.2. Restraints

        3.8.3. Opportunity Analysis

        3.8.4. Trend

4. Global Market Demand (US$ Mn) Analysis 2016-2021 and Forecast, 2022-2032

    4.1. Historical Market Value (US$ Mn) Analysis, 2016-2021

    4.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2016-2021 and Forecast 2022-2032, By Application

    5.1. Introduction / Key Findings

    5.2. Historical Market Value (US$ Mn) Analysis By Application, 2016-2021

    5.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Application, 2022-2032

        5.3.1. Biological/Immunotherapy

        5.3.2. Chemotherapy

        5.3.3. Radiation Therapy

        5.3.4. Targeted Therapy

        5.3.5. Stem Cell Transplantation

    5.4. Market Attractiveness Analysis By Application

6. Global Market Analysis 2016-2021 and Forecast 2022-2032, by End User

    6.1. Introduction / Key Findings

    6.2. Historical Market Value (US$ Mn) Analysis By End User , 2016-2021

    6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By End User, 2022-2032

        6.3.1. Hospitals

        6.3.2. Clinics

        6.3.3. Cancer Rehabilitation Centers

    6.4. Market Attractiveness Analysis By End User

7. Global Market Analysis 2016-2021 and Forecast 2022-2032, by Region

    7.1. Introduction / Key Findings

    7.2. Historical Market Value (US$ Mn) Analysis By Region, 2016-2021

    7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. East Asia

        7.3.5. South Asia & Oceania

        7.3.6. Middle East and Africa (MEA)

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2016-2021 and Forecast 2022-2032

    8.1. Introduction / Key Findings

    8.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    8.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        8.3.1. By Country

            8.3.1.1. U.S.

            8.3.1.2. Canada

        8.3.2. By Application

        8.3.3. By End User

    8.4. Market Attractiveness Analysis

        8.4.1. By Country

        8.4.2. By Application

        8.4.3. By End User

9. Latin America Market Analysis 2016-2021 and Forecast 2022-2032

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        9.3.1. By Country

            9.3.1.1. Brazil

            9.3.1.2. Mexico

            9.3.1.3. Rest of Latin America

        9.3.2. By Application

        9.3.3. By End User

        9.3.4. By End Use

    9.4. Market Attractiveness Analysis

        9.4.1. By Country

        9.4.2. By Application

        9.4.3. By End User

        9.4.4. By End Use

10. Europe Market Analysis 2016-2021 and Forecast 2022-2032

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    10.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        10.3.1. By Country

            10.3.1.1. Germany

            10.3.1.2. France

            10.3.1.3. Italy

            10.3.1.4. Spain

            10.3.1.5. UK

            10.3.1.6. BENELUX

            10.3.1.7. Russia

            10.3.1.8. Rest of Europe

        10.3.2. By Application

        10.3.3. By End User

        10.3.4. By End Use

    10.4. Market Attractiveness Analysis

        10.4.1. By Country

        10.4.2. By Application

        10.4.3. By End User

        10.4.4. By End Use

11. East Asia Market Analysis 2016-2021 and Forecast 2022-2032

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        11.3.1. By Country

            11.3.1.1. China

            11.3.1.2. Japan

            11.3.1.3. South Korea

        11.3.2. By Application

        11.3.3. By End User

        11.3.4. By End Use

    11.4. Market Attractiveness Analysis

        11.4.1. By Country

        11.4.2. By Application

        11.4.3. By End User

        11.4.4. By End Use

12. South Asia & Oceania Market Analysis 2016-2021 and Forecast 2022-2032

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        12.3.1. By Country

            12.3.1.1. India

            12.3.1.2. Thailand

            12.3.1.3. Malaysia

            12.3.1.4. Singapore

            12.3.1.5. Vietnam

            12.3.1.6. ANZ

            12.3.1.7. Rest of South Asia & Oceania

        12.3.2. By Application

        12.3.3. By End User

        12.3.4. By End Use

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Application

        12.4.3. By End User

        12.4.4. By End Use

13. Middle East and Africa Market Analysis 2016-2021 and Forecast 2022-2032

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        13.3.1. By Country

            13.3.1.1. GCC Countries

            13.3.1.2. South Africa

            13.3.1.3. Israel

            13.3.1.4. Rest of Middle East and Africa (MEA)

        13.3.2. By Application

        13.3.3. By End User

        13.3.4. By End Use

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Application

        13.4.3. By End User

        13.4.4. By End Use

14. Market Structure Analysis

    14.1. Market Analysis by Tier of Companies

    14.2. Market Concentration

    14.3. Market Share Analysis of Top Players

    14.4. Market Presence Analysis

15. Competition Analysis

    15.1. Competition Dashboard

    15.2. Competition Benchmarking

    15.3. Competition Deep Dive

    15.4. Novartis Pharmaceuticals

        15.4.1. Company Overview

        15.4.2. Application overview

        15.4.3. SWOT Analysis

        15.4.4. Key Developments

    15.5. Merck & Co. Inc.

        15.5.1. Company Overview

        15.5.2. Application overview

        15.5.3. SWOT Analysis

        15.5.4. Key Developments

    15.6. Bristol-Myers Squibb Company

        15.6.1. Company Overview

        15.6.2. Application overview

        15.6.3. SWOT Analysis

        15.6.4. Key Developments

    15.7. AbbVie Inc.

        15.7.1. Company Overview

        15.7.2. Application overview

        15.7.3. SWOT Analysis

        15.7.4. Key Developments

    15.8. Johnson & Johnson Pvt. Ltd.

        15.8.1. Company Overview

        15.8.2. Application overview

        15.8.3. SWOT Analysis

        15.8.4. Key Developments

    15.9. Teva Pharmaceutical Industries Ltd.

        15.9.1. Company Overview

        15.9.2. Application overview

        15.9.3. SWOT Analysis

        15.9.4. Key Developments

    15.10. Bayer AG

        15.10.1. Company Overview

        15.10.2. Application overview

        15.10.3. SWOT Analysis

        15.10.4. Key Developments

    15.11. Pfizer Inc.

        15.11.1. Company Overview

        15.11.2. Application overview

        15.11.3. SWOT Analysis

        15.11.4. Key Developments

    15.12. Takeda Pharmaceutical Co. Ltd.

        15.12.1. Company Overview

        15.12.2. Application overview

        15.12.3. SWOT Analysis

        15.12.4. Key Developments

16. Assumptions And Acronyms Used

17. Research Methodology
Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Market Value (US$ Mn) Analysis, by Application, 2016-2021

Table 02: Global Market Value (US$ Mn) Analysis, by Application, 2022-2032

Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2032

Table 04: Global Market Value (US$ Mn) Analysis, by End User, 2016-2021

Table 05: Global Market Value (US$ Mn) Analysis, by End User, 2022-2032

Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2022-2032

Table 07: Global Market Value (US$ Mn) Analysis, by End Use, 2016-2021

Table 08: Global Market Value (US$ Mn) Analysis, by End Use, 2022-2032

Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by End Use, 2022-2032

Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2016-2021

Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2022-2032

Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2022-2032

Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2016-2021

Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2022-2032

Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2032

Table 16: North America Market Value (US$ Mn) Analysis, by Application, 2016-2021

Table 17: North America Market Value (US$ Mn) Analysis, by Application, 2022-2032

Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2032

Table 19: North America Market Value (US$ Mn) Analysis, by End User, 2016-2021

Table 20: North America Market Value (US$ Mn) Analysis, by End User, 2022-2032

Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2022-2032

Table 22: North America Market Value (US$ Mn) Analysis, by End Use, 2016-2021

Table 23: North America Market Value (US$ Mn) Analysis, by End Use, 2022-2032

Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End Use, 2022-2032

Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2016-2021

Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2022-2032

Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2032

Table 28: Latin America Market Value (US$ Mn) Analysis, by Application, 2016-2021

Table 29: Latin America Market Value (US$ Mn) Analysis, by Application, 2022-2032

Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2032

Table 31: Latin America Market Value (US$ Mn) Analysis, by End User, 2016-2021

Table 32: Latin America Market Value (US$ Mn) Analysis, by End User, 2022-2032

Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2022-2032

Table 34: Latin America Market Value (US$ Mn) Analysis, by End Use, 2016-2021

Table 35: Latin America Market Value (US$ Mn) Analysis, by End Use, 2022-2032

Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End Use, 2022-2032

Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2016-2021

Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2022-2032

Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2032

Table 40: Europe Market Value (US$ Mn) Analysis, by Application, 2016-2021

Table 41: Europe Market Value (US$ Mn) Analysis, by Application, 2022-2032

Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2032

Table 43: Europe Market Value (US$ Mn) Analysis, by End User, 2016-2021

Table 44: Europe Market Value (US$ Mn) Analysis, by End User, 2022-2032

Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2022-2032

Table 46: Europe Market Value (US$ Mn) Analysis, by End Use, 2016-2021

Table 47: Europe Market Value (US$ Mn) Analysis, by End Use, 2022-2032

Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by End Use, 2022-2032

Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2016-2021

Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2022-2032

Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2032

Table 52: East Asia Market Value (US$ Mn) Analysis, by Application, 2016-2021

Table 53: East Asia Market Value (US$ Mn) Analysis, by Application, 2022-2032

Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2032

Table 55: East Asia Market Value (US$ Mn) Analysis, by End User, 2016-2021

Table 56: East Asia Market Value (US$ Mn) Analysis, by End User, 2022-2032

Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2022-2032

Table 58: East Asia Market Value (US$ Mn) Analysis, by End Use, 2016-2021

Table 59: East Asia Market Value (US$ Mn) Analysis, by End Use, 2022-2032

Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by End Use, 2022-2032

Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2016-2021

Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2022-2032

Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2032

Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2016-2021

Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2022-2032

Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2032

Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2016-2021

Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2022-2032

Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End User, 2022-2032

Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by End Use, 2016-2021

Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by End Use, 2022-2032

Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End Use, 2022-2032

Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2016-2021

Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2022-2032

Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2032

Table 76: MEA Market Value (US$ Mn) Analysis, by Application, 2016-2021

Table 77: MEA Market Value (US$ Mn) Analysis, by Application, 2022-2032

Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2032

Table 79: MEA Market Value (US$ Mn) Analysis, by End User, 2016-2021

Table 80: MEA Market Value (US$ Mn) Analysis, by End User, 2022-2032

Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2022-2032

Table 82: MEA Market Value (US$ Mn) Analysis, by End Use, 2016-2021

Table 83: MEA Market Value (US$ Mn) Analysis, by End Use, 2022-2032

Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by End Use, 2022-2032
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2016-2021

Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2022-2032

Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2016-2032

Figure 04: Global Market Incremental $ Opportunity, 2022-2032

Figure 05: Global Market Share and BPS Analysis by Application, 2022 & 2032

Figure 06: Global Market Y-o-Y Growth Projections by Application, 2022-2032

Figure 07: Global Market Attractiveness Analysis by Application, 2022-2032

Figure 08: Global Market Share and BPS Analysis by End User, 2022 & 2032

Figure 09: Global Market Y-o-Y Growth Projections by End User, 2022-2032

Figure 10: Global Market Attractiveness Analysis by End User, 2022-2032

Figure 11: Global Market Share and BPS Analysis by End Use, 2022 & 2032

Figure 12: Global Market Y-o-Y Growth Projections by End Use, 2022-2032

Figure 13: Global Market Attractiveness Analysis by End Use, 2022-2032

Figure 14: Global Market Share and BPS Analysis by Region, 2022 & 2032

Figure 15: Global Market Y-o-Y Growth Projections by Region, 2022-2032

Figure 16: Global Market Attractiveness Analysis by Region, 2022-2032

Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2016-2021

Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2022-2032

Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2032

Figure 20: North America Market Incremental $ Opportunity, 2022-2032

Figure 21: North America Market Share Analysis by Country, 2022 & 2032

Figure 22: North America Market Y-o-Y Growth Projection by Country, 2022-2032

Figure 23: North America Market Attractiveness Analysis by Country, 2022-2032

Figure 24: North America Market Share and BPS Analysis by Application, 2022 & 2032

Figure 25: North America Market Y-o-Y Growth Projections by Application, 2022-2032

Figure 26: North America Market Attractiveness Analysis by Application, 2022-2032

Figure 27: North America Market Share and BPS Analysis by End User, 2022 & 2032

Figure 28: North America Market Y-o-Y Growth Projections by End User, 2022-2032

Figure 29: North America Market Attractiveness Analysis by End User, 2022-2032

Figure 30: North America Market Share and BPS Analysis by End Use, 2022 & 2032

Figure 31: North America Market Y-o-Y Growth Projections by End Use, 2022-2032

Figure 32: North America Market Attractiveness Analysis by End Use, 2022-2032

Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2016-2021

Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2022-2032

Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2016-2032

Figure 36: Latin America Market Incremental $ Opportunity, 2022-2032

Figure 37: Latin America Market Share Analysis by Country, 2022 & 2032

Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2022-2032

Figure 39: Latin America Market Attractiveness Analysis by Country, 2022-2032

Figure 40: Latin America Market Share and BPS Analysis by Application, 2022 & 2032

Figure 41: Latin America Market Y-o-Y Growth Projections by Application, 2022-2032

Figure 42: Latin America Market Attractiveness Analysis by Application, 2022-2032

Figure 43: Latin America Market Share and BPS Analysis by End User, 2022 & 2032

Figure 44: Latin America Market Y-o-Y Growth Projections by End User, 2022-2032

Figure 45: Latin America Market Attractiveness Analysis by End User, 2022-2032

Figure 46: Latin America Market Share and BPS Analysis by End Use, 2022 & 2032

Figure 47: Latin America Market Y-o-Y Growth Projections by End Use, 2022-2032

Figure 48: Latin America Market Attractiveness Analysis by End Use, 2022-2032

Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2016-2021

Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2022-2032

Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2016-2032

Figure 52: Europe Market Incremental $ Opportunity, 2022-2032

Figure 53: Europe Market Share Analysis by Country, 2022 & 2032

Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2022-2032

Figure 55: Europe Market Attractiveness Analysis by Country, 2022-2032

Figure 56: Europe Market Share and BPS Analysis by Application, 2022 & 2032

Figure 57: Europe Market Y-o-Y Growth Projections by Application, 2022-2032

Figure 58: Europe Market Attractiveness Analysis by Application, 2022-2032

Figure 59: Europe Market Share and BPS Analysis by End User, 2022 & 2032

Figure 60: Europe Market Y-o-Y Growth Projections by End User, 2022-2032

Figure 61: Europe Market Attractiveness Analysis by End User, 2022-2032

Figure 62: Europe Market Share and BPS Analysis by End Use, 2022 & 2032

Figure 63: Europe Market Y-o-Y Growth Projections by End Use, 2022-2032

Figure 64: Europe Market Attractiveness Analysis by End Use, 2022-2032

Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2016-2021

Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2022-2032

Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2016-2032

Figure 68: East Asia Market Incremental $ Opportunity, 2022-2032

Figure 69: East Asia Market Share Analysis by Country, 2022 & 2032

Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2022-2032

Figure 71: East Asia Market Attractiveness Analysis by Country, 2022-2032

Figure 72: East Asia Market Share and BPS Analysis by Application, 2022 & 2032

Figure 73: East Asia Market Y-o-Y Growth Projections by Application, 2022-2032

Figure 74: East Asia Market Attractiveness Analysis by Application, 2022-2032

Figure 75: East Asia Market Share and BPS Analysis by End User, 2022 & 2032

Figure 76: East Asia Market Y-o-Y Growth Projections by End User, 2022-2032

Figure 77: East Asia Market Attractiveness Analysis by End User, 2022-2032

Figure 78: East Asia Market Share and BPS Analysis by End Use, 2022 & 2032

Figure 79: East Asia Market Y-o-Y Growth Projections by End Use, 2022-2032

Figure 80: East Asia Market Attractiveness Analysis by End Use, 2022-2032

Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2016-2021

Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2022-2032

Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2016-2032

Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2022-2032

Figure 85: South Asia & Oceania Market Share Analysis by Country, 2022 & 2032

Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2022-2032

Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2022-2032

Figure 88: South Asia & Oceania Market Share and BPS Analysis by Application, 2022 & 2032

Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Application, 2022-2032

Figure 90: South Asia & Oceania Market Attractiveness Analysis by Application, 2022-2032

Figure 91: South Asia & Oceania Market Share and BPS Analysis by End User, 2022 & 2032

Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by End User, 2022-2032

Figure 93: South Asia & Oceania Market Attractiveness Analysis by End User, 2022-2032

Figure 94: South Asia & Oceania Market Share and BPS Analysis by End Use, 2022 & 2032

Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by End Use, 2022-2032

Figure 96: South Asia & Oceania Market Attractiveness Analysis by End Use, 2022-2032

Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2016-2021

Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2022-2032

Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2016-2032

Figure 100: MEA Market Incremental $ Opportunity, 2022-2032

Figure 101: MEA Market Share Analysis by Country, 2022 & 2032

Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2022-2032

Figure 103: MEA Market Attractiveness Analysis by Country, 2022-2032

Figure 104: MEA Market Share and BPS Analysis by Application, 2022 & 2032

Figure 105: MEA Market Y-o-Y Growth Projections by Application, 2022-2032

Figure 106: MEA Market Attractiveness Analysis by Application, 2022-2032

Figure 107: MEA Market Share and BPS Analysis by End User, 2022 & 2032

Figure 108: MEA Market Y-o-Y Growth Projections by End User, 2022-2032

Figure 109: MEA Market Attractiveness Analysis by End User, 2022-2032

Figure 110: MEA Market Share and BPS Analysis by End Use, 2022 & 2032

Figure 111: MEA Market Y-o-Y Growth Projections by End Use, 2022-2032

Figure 112: MEA Market Attractiveness Analysis by End Use, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Multiple Myeloma Diagnostics Market

Published : July 2019

Healthcare

Genetic Leukemia Detection Testing Market

Published : May 2018

Healthcare

Chronic Lymphocytic Leukemia Market

Published : December 2016

Healthcare

Leukemia Therapeutics Treatment Market

Published : February 2022

Google translate

Blood Cancer (leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma) Treatment Market